IPHA Innate Pharma S.A.
$1.59
Innate Pharma S.A. (IPHA) Earnings News
Earnings press releases, previews and reviews for Innate Pharma S.A. (IPHA), newest first. Our most recent is review: Innate Pharma's Sobi Deal Rewrites the Funding Story — But Phase 3 Enrollment Slipped Again.
Thursday
September 17, 2026
12:16 PM ET
Innate Pharma's Sobi Deal Rewrites the Funding Story — But Phase 3 Enrollment Slipped Again
Earnings Whispers · Review
Thursday
September 17, 2026
1:00 AM ET
Innate Pharma Reports First Half 2026 Business Update and Financial Results
Thursday
September 10, 2026
1:00 AM ET
Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update